Nuvectis Pharma, Inc.
USD19.08
+1.05 (+5.82%)
CEO
Ron Bentsur
IPO Date
2022-02-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$18.91
Prev. Close
$18.03
Day Low
$18.21
Day High
$19.70
52W Low
$5.55
52W High
$29.27
Market Cap
$0.51B
Volume
0.19M
| 12,500 |
| $20.00 |
| 12 Jun 2026 | Hoberman Kenneth | director | A-Award | Acquired | 35,000 | $0.00 |
| 12 Jun 2026 | Oliviero James F III | director | A-Award | Acquired | 35,000 | $0.00 |
| 12 Jun 2026 | Sanchez Juan | director | A-Award | Acquired | 35,000 | $0.00 |
| 12 Jun 2026 | Kaplan Matthew L. | director | A-Award | Acquired | 35,000 | $0.00 |
| 9 Jan 2026 | Shemesh Shay | Chief Dev. & Ops. Officer | A-Award | Acquired | 150,000 | $0.00 |
| 9 Jan 2026 | BENTSUR RON | director, 10 percent owner, officer: Chairman & CEO | A-Award | Acquired | 150,000 | $0.00 |
| 9 Jan 2026 | Poradosu Enrique | Chief Science & Business Off | A-Award | Acquired | 150,000 | $0.00 |
| 9 Jan 2026 | Carson Michael J. | Vice President, Finance | A-Award | Acquired | 61,200 | $0.00 |